285 related articles for article (PubMed ID: 28236697)
1. Budget impact of perampanel as adjunctive treatment of uncontrolled partial-onset and primary generalized tonic-clonic seizures in the United States.
Tremblay G; Barghout V; Patel V; Tsong W; Wang Z
Epilepsy Behav; 2017 Mar; 68():196-202. PubMed ID: 28236697
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of perampanel for the treatment of primary generalized tonic-clonic seizures (PGTCS) in epilepsy: A Spanish perspective.
Tremblay G; Howard D; Tsong W; Patel V; De Rosendo J
Epilepsy Behav; 2018 Sep; 86():108-115. PubMed ID: 30001911
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
Trigg A; Brohan E; Cocks K; Jones A; Tahami Monfared AA; Chabot I; Meier G; Campbell R; Li H; Ngo LY
Epilepsy Behav; 2021 May; 118():107938. PubMed ID: 33839450
[TBL] [Abstract][Full Text] [Related]
4. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
[TBL] [Abstract][Full Text] [Related]
5. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
[No Abstract] [Full Text] [Related]
6. Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States.
Faught E; Laliberté F; Wang Z; Barghout V; Haider B; Lejeune D; Germain G; Choi J; Wagh A; Duh MS
Epilepsia; 2017 Oct; 58(10):1742-1748. PubMed ID: 28741690
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations.
Nishida T; Lee SK; Wu T; Tiamkao S; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():47-59. PubMed ID: 30869168
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Kaneko S
Acta Neurol Scand; 2018 Apr; 137(4):392-399. PubMed ID: 29250772
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
11. Perampanel: A Review in Drug-Resistant Epilepsy.
Frampton JE
Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
[TBL] [Abstract][Full Text] [Related]
12. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Rohracher A; Brigo F; Höfler J; Kalss G; Neuray C; Dobesberger J; Kuchukhidze G; Leitinger M; Trinka E
Expert Opin Pharmacother; 2016 Jul; 17(10):1403-11. PubMed ID: 27267634
[TBL] [Abstract][Full Text] [Related]
13. Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studies.
Leppik IE; Yang H; Williams B; Zhou S; Fain R; Patten A; Bibbiani F; Laurenza A
Epilepsia; 2017 Jan; 58(1):51-59. PubMed ID: 27869305
[TBL] [Abstract][Full Text] [Related]
14. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F
Neurology; 2015 Sep; 85(11):950-7. PubMed ID: 26296511
[TBL] [Abstract][Full Text] [Related]
15. PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis.
Steinhoff BJ; Goldmann T; Kockelmann E; Winter Y;
Epilepsia Open; 2024 Jun; 9(3):926-939. PubMed ID: 38017663
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures.
de Biase S; Gigli GL; Nilo A; Romano G; Valente M
Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):93-102. PubMed ID: 30577702
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy.
Faulkner MA
Drug Des Devel Ther; 2017; 11():2921-2930. PubMed ID: 29042752
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.
Mehndiratta MM; Gulhane M; Jabeen SA; Patten A; Dash A; Malhotra M
Epilepsia Open; 2021 Mar; 6(1):90-101. PubMed ID: 33681652
[TBL] [Abstract][Full Text] [Related]
20. Electro-clinical analysis of epilepsy patients with generalized seizures on adjunctive perampanel treatment.
Montoya Gutiérrez FJ; Díaz Román M; Cerveró Albert D
Epilepsy Res; 2020 Sep; 165():106378. PubMed ID: 32622260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]